IHR

Health and Pharmaceutical Research in Iraq , Jordan and the MENA Region

Founded in 2016 under the dedication of IIACSS, IHR (infographic for Health Research ) is a leading marketing research organization specializing in the health and pharmaceutical sectors across all 18 provinces of Iraq. Our expertise lies in building strong partnerships with key opinion leaders, physicians, and professionals across various clinical sectors.

IHR is proud to be the first market research company to conduct on-field qualitative and quantitative pharmaceutical research in Iraq, beginning in 2007. Our team consists of senior pharmacists, medical doctors, and healthcare professionals (HCPs) with over 15 years of experience in both the public and private sectors.

Since 2019, we have expanded our services to include clinical research, particularly in the field of rare diseases, further establishing our commitment to advancing healthcare in Iraq.

F2F interview

FG and IDI

Healthcare outlets

Years in Business

Retail Auditing

IHR has partnered with IQVIA (Formerly known as QunitilesIMS) to produce their first Iraqi Retail Auditing report Across Iraq. This report was generated on quarterly basis for the Private Market at a semi national level by collecting data from Drugstores and Pharmacies projected on Baghdad, Basra and Kurdistan region. A syndicated pharmaceutical database, our report can offer a wider understanding to the Iraqi market. As It gives better answers to pharmaceutical industries in terms of tracking their product performance, their sales per SKU over a period, to figure out their market share, and their position in comparison with other competitors.

Qualitative  Research.

Qualitative research plays a vital role in health projects by uncovering the deeper insights behind patient experiences and healthcare provider perspectives. Through methods like in-depth interviews, focus groups, and observational studies, we explore the social and behavioral factors that influence health outcomes. This approach allows us to identify unmet needs, improve patient care, and guide more effective health interventions by focusing on the human aspect of health beyond just data and statistics.

Quantitative Research

Providing a systematic and objective way to collect and analyze numerical data and utilizing surveys and statistical analysis; This approach allows us to measure health outcomes, identify trends, and evaluate the effectiveness of interventions. By converting complex health issues into quantifiable metrics, we can make data-driven decisions that enhance public health initiatives, improve patient outcomes, and allocate resources more effectively. This robust methodology ensures that our findings are reliable and can be generalized to broader populations

Clinical Trials

Aiming to strengthen our presence in this field by thoroughly studying and understanding the procedures and foundations required for clinical studies in Iraq, Jordan and the region, as well as addressing the unmet needs in this area. IHR has collaborated with RAY, providing logistical support for the DBS project over the past 4 years , successfully managing more than 6,000 samples

Ad hoc Research.

Ad hoc research in the health sector is a customized approach to gathering critical insights for specific healthcare challenges. Unlike ongoing studies, ad hoc research is designed to address unique, one-time questions, providing targeted and timely data. Whether it’s assessing patient behavior, evaluating public health trends, or gathering feedback on healthcare services, this method delivers actionable insights. By focusing on pressing health issues, ad hoc research supports organizations in making informed, evidence-based decisions that improve healthcare outcomes and address emerging needs

Therapeutic Area

Most of the projects implemented by IHR have been in the fields of oncology, hematology, and cardiology, which has allowed us to establish strong relationships with doctors in these specialties

Market Health Technology Assessment (HTA)

Regulatory affairs, Market Access and Pricing